Detalles de la búsqueda
1.
Nintedanib for the treatment of patients with refractory metastatic colorectal cancer (LUME-Colon 1): a phase III, international, randomized, placebo-controlled study.
Ann Oncol
; 29(9): 1955-1963, 2018 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30010751
2.
Anthracycline-based triplets do not improve the efficacy of platinum-fluoropyrimidine doublets in first-line treatment of advanced gastric cancer: real-world data from the AGAMEMON National Cancer Registry.
Gastric Cancer
; 21(1): 96-105, 2018 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-28393278
3.
Nomogram-based prediction of survival in patients with advanced oesophagogastric adenocarcinoma receiving first-line chemotherapy: a multicenter prospective study in the era of trastuzumab.
Br J Cancer
; 116(12): 1526-1535, 2017 Jun 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-28463962
4.
Prospective transGEICAM study of the impact of the 21-gene Recurrence Score assay and traditional clinicopathological factors on adjuvant clinical decision making in women with estrogen receptor-positive (ER+) node-negative breast cancer.
Ann Oncol
; 23(3): 625-631, 2012 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-21652577
5.
Sex and gender disparities in patients with advanced gastroesophageal adenocarcinoma: data from the AGAMENON-SEOM registry.
ESMO Open
; 7(3): 100514, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35714478
6.
Optimal duration of first-line chemotherapy for advanced gastric cancer: data from the AGAMENON registry.
Clin Transl Oncol
; 22(5): 734-750, 2020 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-31385226
7.
Efficacy of trifluridine and tipiracil (TAS-102) versus placebo, with supportive care, in a randomized, controlled trial of patients with metastatic colorectal cancer from Spain: results of a subgroup analysis of the phase 3 RECOURSE trial.
Clin Transl Oncol
; 19(2): 227-235, 2017 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-27443414
Resultados
1 -
7
de 7
1
Próxima >
>>